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Titin is an extremely large protein found in highest concentrations in heart and skeletal muscle. The single mammalian gene is
expressed in multiple isoforms as a result of alternative splicing. Although titin isoform expression is controlled developmentally
andinatissuespeciﬁcmanner,thevastnumberofpotentialsplicingpathwaysfarexceedsthosedescribedinanyotheralternatively
spliced gene. Over 1 million human splice pathways for a single individual can be potentially derived from the PEVK region alone.
A new splicing pattern for the human cardiac N2BA isoform type has been found in which the PEVK region includes only the N2B
type exons. The alterations in splicing and titin isoform expression in human heart disease provide impetus for future detailed
study of the splicing mechanisms for this giant protein.
1.Introduction
Titin is the third most abundant protein (after myosin
and actin) in vertebrate striated muscle, with an average
adult human containing ∼0.5kg [1]. This extremely large
protein [2], which is also known as connectin [3], spans
each half sarcomere from the Z-line to the M-line or center
of the sarcomere [4, 5]( Figure 1). The C-terminal A-band
segment of titin is attached to the thick ﬁlament via multiple
binding sites for myosin and C-protein [6] and two C-
terminal titin regions from adjacent half-sarcomeres overlap
in the M-line region of the sarcomere [7]. Similarly titin’s
N-terminal segment is anchored in the Z-disk and overlaps
another titin N-terminus from the adjacent sarcomere [8].
Titin thus constitutes a continuous ﬁlament system along
the myoﬁbril. Titin is believed to function as a template
in sarcomere assembly and for maintenance of sarcomere
integrity [9, 10]( Figure 1). These concepts have been
conﬁrmed by recent work showing that titin loss in long-
term disuse of skeletal muscle results in the disorganization
of the ordered sarcomeric structure [11, 12]. Each end of
the thick ﬁlament is linked to the nearest Z-disk by titin.
This provides axial continuity for the production of resting
tension and maintains the thick ﬁlament in the center of
sarcomere during generation of active force [13]. Titin’s
several extensible elements establish titin as a critical, multi-
functionalsarcomericcomponent.Theseextensibleelements
are composed of (1) Tandem Ig segments (consisting of
serially linked immunoglobulin-like domains), (2) the PEVK
region(socalledforitshighcontentofproline(P),glutamate
(E), valine (V), and lysine (K) residues), and (3) the cardiac-
speciﬁc N2B unique sequence (N2B-Us) (Figure 1). In slack
sarcomeres the tandem Ig and PEVK segments are collapsed.
Upon initial stretch, the collapsed tandem Ig segments are
straightened while their individual Ig domains remained
folded. With further stretch the PEVK region extends [14,
15]. Modeling tandem Ig and PEVK segments as entropic
springs with diﬀerent bending rigidities indicated that in
the physiological SL range (a) the Ig-like domains of the
tandem Ig segments remain folded and (b) the PEVK
segment behaves as a permanently unfolded polypeptide
[16–19]. The cardiac-speciﬁc N2B unique sequence (N2B-
Us)formsathirdspringelementincardiactitinandprovides
extensibility at the upper range of physiological sarcomere
lengths in the heart [17, 20–23].
The original description of titin isoforms suggested that
the N2B unique sequence occurred in cardiac muscle and a
diﬀerentuniqueregioncalledN2Awasfoundonlyinskeletal
muscles.Namesofthefullisoformsinthesetissueswerethen
N2B and N2A, respectively [5]. It was later found that the
myocardium expresses two major classes of titin isoforms:
a smaller N2B and a larger N2BA that contained both the
N2B and N2A unique sequences [24, 25]( Figure 2). All these
known titin isoforms contain PEVK and tandem Ig segments2 Journal of Biomedicine and Biotechnology
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Figure 1: Titin location and arrangement in the cardiac sarcomere.
[5, 25, 26]. The N2B isoform has fewer Ig domains and a
short PEVK region; the N2A class of isoforms contains more
Ig domains and a somewhat longer PEVK region. Nearly all
Z-disk and A-band/M-band titin domains are constitutively
expressed in titin isoforms of human cardiac muscle. The
main titin diﬀerential splicing occurs in the middle Ig and
PEVK domains of the I-band-titin segment [24, 27].
The current review will discuss the isoforms of titin and
the alternative splicing patterns that lead to the diﬀerent
forms. A number of excellent reviews should be consulted
for further details on the structure and function of titin
[6, 19, 28–33].
2.ElectrophoresisDetectionofTitin
Titin is the biggest protein in the human body, and there
are a number of size variants. The earliest reports indicated
that there were two electrophoretic bands: a larger T1 (which
was the full length version) and T2 (a proteolytic fragment
extending from the PEVK region through the carboxyl
terminal M line end) [2]. Because of titin’s extremely large
size, migration is minimal in typical SDS polyacrylamide
gels,andithasbeendiﬃculttodevelopareliableandquanti-
tative gel procedure. An earlier study used 3.3–12% gradient
polyacrylamide gels to detect and quantify titin and nebulin
from short segments of single muscle ﬁbers [34]. This system
separated titin T1 (intact titin, Mr ∼3300kDa) and T2
(breakdown product of titin, Mr ∼2000kDa). Another group
employed 2% polyacrylamide slab gels strengthened with
agarose to resolve two T1 bands plus the T2 [35]. More
recently 2–9.5% acrylamide gradient gels have been used to
separate the large titin isoforms and fragments [25]. These
gels showed that the T1 mobility varied greatly between
musclesources,reﬂectingthediﬀerenceinmolecularmassof
the 3.7-MDa soleus titin and the 2.97-MDa rat cardiac titin
isoform. The two major T1 bands were ascribed to the titin
isoforms N2B and N2BA in cardiac muscle.
However, the gels mentioned above are physically dif-
ﬁcult to work with, are more complex to pour, and often
undergo distortion or tearing during ﬁxing and staining. It is
also very diﬃcult to transfer large proteins out of acrylamide
gels for Western blotting. More recently our group has
developed a diﬀerent more reliable and reproducible system
called vertical SDS-agarose gel electrophoresis (VAGE) [36].
This method employs Sea Kem Gold agarose and allows
high-resolution separation of titin isoforms. In addition the
blot transfer eﬃciency was almost 100% [36]. This system
can also be easily adapted for the characterization of other
very large proteins from a variety of sources.
The SDS agarose system resolves at least four classes
of N2BA titin isoforms. Two rat embryonic/neonatal forms
(N2BA-N1; N2BA-N2) with apparent sizes of approximately
3710 and 3590kDa, respectively, are found during late
embryonic and immediately after birth [37]. These are
graduallyreplacedbytwoadultforms(N2BA-A1;N2BA-A2)
with sizes of 3390 and 3220. It has been postulated that these
shorterversionsareduetodeletionoflargenumbersofexons
from the exon 50 to 71 and 50 to 90 middle Ig regions (see
below) [37].
3.TitinTissueandSpeciescDNA
SequenceComparisons
Early cDNA sequencing of titin from human cardiac and
soleus indicated that both isoforms were derived from a
single gene and obtained by alternative splicing [5, 24]. The
single titin gene contained 363 exons [27]. The complete
cDNA and genomic sequence determination of human
cardiac titin have provided a template for later study of titin
splicing variants.
3.1. M Line Region. Kolmerer and coworkers [39] searched
for alternatively expressed exons in the M-line region of titin
and found that six exons (called Mex1 to 6) coded for theJournal of Biomedicine and Biotechnology 3
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Figure 2: Domain arrangement of diﬀerent titin isoforms. Arrows indicate the exons spliced, solid line connections denote consecutive
exons. Cross-hatch pattern in PEVK indicates variable patterns of skipped exons.
most carboxyl terminus of titin. Message for human cardiac
titin always included exon Mex5 while rabbit cardiac titin
message contained small amounts with the Mex5 missing
and mouse hearts had approximately equal proportions of
Mex5 (+) and Mex5 (−). Rabbit skeletal muscles contained
varying ratios of Mex5 (+) and Mex5 (−). The proportion
of Mex5 (+) containing message (and presumably the titin
segment it codes) appears to correlate with the M line ﬁne
structure diﬀerences that occur between tissues [40–42],
developmental stage [43], and species [44].
3.2. Z-Disk Region. The Z-disk region of titin consists of
4 Ig-domains (Z1 to Z4) with large interdomain insertions
betw eenZ2andZ3andbetw eenZ3andZ4[5,45].Thelatter
insertioncontainsaseriesof45aminoacidresiduerepeats(Z
repeats). Alternative splicing results in the expression of 6 or
7 repeats in human and rabbit heart, 4 to 6 in slow skeletal
muscle, and 2 to 4 in fast skeletal muscle [46]. The number
of repeats correlates with the Z line thickness [45, 46].
3.3. I-Band Region. The I-band region of titin is believed to
be responsible for the myoﬁbrillar passive tension response
to stretch. Surprisingly the splicing patterns of highly diverse
titins are exceptionally complex. N2B titin isoforms have the
most simple splice plans. Exon 50 (I27) is usually spliced to
exon 219. This splicing pattern has been veriﬁed in human,
rabbit, rat, and pig hearts [38]. PCR ampliﬁcation with
primers from I27 to I84 of rabbit, pig, and rat ventricle is
consistent with an expected size of 760bp (based on the
human sequence). Dog heart yielded two fragments (a major
615bp and a minor 760bp) and the amino acid sequence
deduced from the nucleotide sequences revealed that the dog4 Journal of Biomedicine and Biotechnology
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Figure 3: Exon inclusion in clones from the human titin PEVK region. Data from left ventricle samples of ﬁve diﬀerent individuals—three
normal (NH-1, NH-2, NH-3), one restrictive cardiomyopathy (RCM), and one dilated cardiomyopathy (DCM). Exon number is listed
across the top. Filled boxes denote exon inclusion. Letter designations in each block refer to separate clones from each individual. Clones
were obtained by PCR ampliﬁcation after RT-PCR using primers from exons 108 and 225. Full details on the methods have been published
[38]. Data from sample NH-1 is from [38]a n df o rN H - 2c l o n e sf r o m[ 37].
ventricleshortPEVKpeptidecontainsadeletionof53amino
acid residues from the amino terminal end of the N2B PEVK
region (corresponding to exons 219 and 220). The absence of
exon 224 also occurs in some clones from human heart (see
Figure 3 and discussion below).
Variable numbers of titin exons between 50 and 219,
including the N2A unique region, are expressed in cardiac
and skeletal muscle. This splicing pattern gives rise to the
N2A protein isoforms in skeletal muscle and the N2BA
isoforms in cardiac muscle [24, 27]. N2BA isoforms (con-
taining both N2A and N2B unique elements) have multiple
splicing pathways in the I27 to I68 segment (Figure 2). Splice
pathways have been identiﬁed between I27 (exon 50) and
exons 51, 70, 71, 75, 77, 80, and 90 [24, 38]. The expression
of more middle Ig domains in fetal rat ventricle is consistent
with the larger size of fetal titin N2BA isoforms observed by
electrophoresis [37].
The N2B unique exon 49 is excluded in skeletal muscles
by splicing together I15 to I27, and only human soleus
muscle expresses consecutive exons between 50 and 102 (I27
to I79). Rabbit psoas muscle skips I30 to I47 (Figure 2).
Altogether, skeletal titin transcripts always include the N2A
segment and exclude the N2B exon; cardiac titins always
include the N2B exon [24].
The N2BA PEVK region has an exceptionally varied
pattern of splicing (Figure 3). Initial studies with dog
cardiac muscle resulted in six clones (A46 A-F) [38], all
from the same PCR ampliﬁcation, having diﬀerent exon
patterns and PEVK lengths (703, 788, 894, 900, 703, and
819 amino acids respectively). Subsequent work with the
human PEVK revealed that 10 diﬀerent clones from a single
individual had 10 diﬀerent patterns of splicing [26]. In
addition a completely new pattern of N2BA splicing has
been recently obtained in which exon 108, found only in
N2BA isoforms, was directly linked to the constitutively
expressed PEVK cluster in the 219 to 225 exon region
(Figure 3). This so-called “short PEVK N2BA” class of
isoforms has been observed in clones from both healthy
and diseased hearts. Such a pattern would result in titin
molecules with apparently less potential PEVK extension
during stretch and thus leads to a stiﬀer sarcomere. It is not
clear whether such message types are expressed into protein
and whether there are a signiﬁcant proportion of such
messagestranscribedtoaﬀectthepassivetension.However,if
an increased proportion of these splicing products occurred
with aging, for example, it might partially explain the
increased cardiac stiﬀness that often occurs during the later
period of life.Journal of Biomedicine and Biotechnology 5
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Figure 4: Exon inclusion in clones from rat left ventricle of wild type and mutant rats. The percent of clones that contain the exons shown is
plottedversusexonposition.Onlyexons115,224,and225werefoundinallwildtypeandmutantclones(heterozygote[Ht]andhomozygote
[Hm]). Data was pooled from four diﬀerent ages [47].
A mutant rat model has been recently described that
results in signiﬁcant alterations in titin isoform expression
[26, 47] .H o m o z y o g o u sm u t a n t se x p r e s sag i a n tt i t i nw i t h
apparent size on SDS agarose gels of about 3.9MDa. This is
larger than the size of titin from human soleus (3.7MDa).
Since the soleus sequence includes all the middle Ig domains
and virtually all the Ig domains from the rest of the gene, it
was initially assumed that the mutant rat heart must then
express the full PEVK exon cohort plus the N2B unique
region. Sequences obtained from PCR clones bridging the
exon108to225regionwerenotmuchlargerthanthosefrom
wild type [47]. Comparisons of exon expression between
wild type and mutants showed some diﬀerences, primarily
in the exon region between 175 and 219 typically associated
withfetalexons(Figure 2)[26,48].Thusitappearsthatmore
than one mechanism must be involved in titin splicing. The
lackofadditionalPEVKexonsinthemutantsexacerbatesthe
mass calculation. The inclusion of the N2B unique region
would add some mass, but the possible inclusion of exon 48
would add 243 kDa. This idea remains to be veriﬁed.
The number of potential PEVK splice variants is huge.
Among the ten clones from the normal human 2 in Figure 3
humancloneslisted,thereare20exonsthatarenotpresentin
all clones. If all these splicing events were independent, this
means that there are 220 combinations, a total of 1,048,576
possible pathways. This far exceeds the approximately 38,016
potentialsplicevariantsidentiﬁedpreviouslywiththeDscam
(Down syndrome cell adhesion molecule) gene [49, 50]. If
all the clones in this table from 5 diﬀerent individuals are
included,thenthereare38diﬀerentialexonsandthenumber
of potential clones exceeds 274 billion.
Microarrays have also been used to compare tissue
sourcesforexonexpression[48,51].Fetaltitinsexpressmore
middle Ig domains and additional PEVK exons. Theseresults
are consistent with the cloning and sequencing results [37].
The identiﬁcation of exon 156 as skeletal muscle speciﬁc [48]
is also consistent with the absence of this exon from every
human (Figure 4) and rat cardiac clone we have sequenced
[47]. Microarrays give more global information since all
messages from a sample are included. Their disadvantages
include the fact that almost no splicing information can be
obtainedandtheresultsincludepooled datafromalltitins in
the sample, including the Novex isoforms. Additionally the
duplication of three segments of the titin gene in the region
of the PEVK [27] means that some microarray probes are
identical. The cloning approach yields actual splice patterns.
The major disadvantages include the fact that only possible
splicepatternsaresampledandthatidentiﬁedclonesmaynot
adequately represent, either quantitatively or qualitatively,
the actual tissue patterns. However, the cloning approach
has veriﬁed that titin splicing is highly diverse, and this
complicates interpretation of mechanical experiments.
4. TheRatioofTitinIsoformsandHeartDisease
Titin isoform splicing not only generates diversity of titin
isoformsinskeletalmuscle[52],butalsoresultsinchangesof6 Journal of Biomedicine and Biotechnology
the ratio of titin isoforms (N2BA/N2B) during heart devel-
opment. Before birth, mammalian heart mainly expresses
more compliant N2BA isoforms. During perinatal heart
development the larger N2BA isoform is gradually replaced
by a smaller isoform N2B, and the N2B isoform becomes
the predominant titin isoform in the adult left ventricles
(LV) of smaller mammalian species [37, 53, 54]. The N2BA
titin isoform prevails over N2B in the adult hearts of larger
mammals, including humans [25, 55]. Recent studies have
shown that the ratio of titin isoforms is altered in some heart
diseases. A canine tachycardia-induced model of dilated car-
diomyopathy (DCM) used to understand titin response to a
chronic mechanical challenge of the heart indicated that two
weeks of pacing gives rise to an exaggerated transmural titin
isoform ratio gradient [56] and four weeks of pacing results
in a decrease of the N2BA/N2B titin ratio, accompanied
by an increase in titin-based passive tension [57]. Another
study of spontaneously hypertensive rat model (SHR) also
showed a reduced ratio of N2BA/N2B titin in response to
pressure overload, consistent with elevated passive tension
of heart [58]. More recent analyses showed that the left
ventricle biopsies from patients with diastolic heart failure
(HF) had a reduced N2BA/N2B titin [59]. Chronically
ischemic LVs of coronary-artery-disease (CAD) patients
with congestive heart failure (HF) had nearly 50% N2BA
titin (compared to N2BA+N2B) while approximate 30%
N2BA was found in the LVs of control donor patients [60].
Analysis of explanted nonischaemic human DCM hearts
again demonstrated increased proportions of N2BA/N2B
[61, 62]. These results are similar to the recently described
rat model with lower ejection fraction (unpublished data)
which expresses the N2BA isoform almost exclusively [26,
47]. Long-term hypothyroidism (which results in diastolic
dysfunction) changed the titin isoform ratios as well. Propy-
lthiouracil(PTU)treatmentinratsinducedtheexpressionof
additional cardiac PEVK and I domain exons similar to those
in the large titin isoform of the fetal heart. Consequently,
titin-based passive and restoring forces were found to be
signiﬁcantly reduced in cardiac muscle of PTU-treated rats
[63, 64]. The mechanisms controlling titin splicing remain
unknown, but the ability to manipulate the splicing of this
protein has great potential for aﬀecting human health.
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